{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:48Z","timestamp":1786119588020,"version":"build-2736575974"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/inf.0b013e3181ff9795","type":"journal-article","created":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T03:24:36Z","timestamp":1288581876000},"page":"e1-e8","source":"Crossref","is-referenced-by-count":14,"title":["Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children"],"prefix":"10.1097","volume":"30","author":[{"given":"Riyadh D.","family":"Muhammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penina","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanie","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Miles","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann W.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-32-20210202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/338363","article-title":"Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study.","volume":"185","author":"Neuzil","year":"2002","journal-title":"J Infect Dis"},{"key":"R2-32-20210202","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archpedi.156.10.986","article-title":"Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families.","volume":"156","author":"Neuzil","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R3-32-20210202","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1542\/peds.113.3.585","article-title":"Incidence of outpatient visits and hospitalizations related to influenza in infants and young children.","volume":"113","author":"O'Brien","year":"2004","journal-title":"Pediatrics"},{"key":"R4-32-20210202","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/424527","article-title":"Burden of influenza in children in the community.","volume":"190","author":"Heikkinen","year":"2004","journal-title":"J Infect Dis"},{"key":"R5-32-20210202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States.","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"R6-32-20210202","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1056\/NEJMoa051721","article-title":"Influenza-associated deaths among children in the United States, 2003\u20132004.","volume":"353","author":"Bhat","year":"2005","journal-title":"N Engl J Med"},{"issue":"RR-07","key":"R7-32-20210202","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.","volume":"57","author":"Fiore","year":"2008","journal-title":"Morb Mortal Wkly Rep"},{"key":"R8-32-20210202","first-page":"333","article-title":"Recommendation of the Immunization Practices Advisory Committee. Influenza vaccines, 1983\u20131984.","volume":"32","year":"1983","journal-title":"Morb Mortal Wkly Rep"},{"issue":"RR-08","key":"R9-32-20210202","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"52","author":"Bridges","year":"2003","journal-title":"Morb Mortal Wkly Rep"},{"issue":"RR-06","key":"R10-32-20210202","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"53","author":"Harper","year":"2004","journal-title":"Morb Mortal Wkly Rep"},{"issue":"RR-10","key":"R11-32-20210202","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Smith","year":"2006","journal-title":"Morb Mortal Wkly Rep"},{"key":"R12-32-20210202","doi-asserted-by":"crossref","first-page":"S507","DOI":"10.1093\/infdis\/136.Supplement_3.S507","article-title":"Serologic responses and systemic reactions in adults after vaccination with bivalent A\/Victoria\/75-A\/New Jersey\/76 and monovalent B\/Hong Kong\/72 influenza vaccines.","volume":"136","author":"Wise","year":"1977","journal-title":"J Infect Dis"},{"key":"R13-32-20210202","doi-asserted-by":"crossref","first-page":"S491","DOI":"10.1093\/infdis\/136.Supplement_3.S491","article-title":"Acceptability and antigenicity of influenza A\/Victoria\/75 virus vaccines in adults of different ages.","volume":"136","author":"Gwaltney","year":"1977","journal-title":"J Infect Dis"},{"key":"R14-32-20210202","doi-asserted-by":"crossref","first-page":"S484","DOI":"10.1093\/infdis\/136.Supplement_3.S484","article-title":"Reactogenicity and immunogenicity of parenteral monovalent influenza A\/Victoria\/3\/75 (H3N2) virus vaccine in healthy adults.","volume":"136","author":"Caplan","year":"1977","journal-title":"J Infect Dis"},{"key":"R15-32-20210202","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.vaccine.2009.01.125","article-title":"Safety of trivalent inactivated influenza vaccine in adults: background for pandemic influenza vaccine safety monitoring.","volume":"27","author":"Vellozzi","year":"2009","journal-title":"Vaccine"},{"key":"R16-32-20210202","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1542\/peds.2004-1519","article-title":"Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the Vaccine Adverse Event Reporting System, 1990\u20132003.","volume":"115","author":"McMahon","year":"2005","journal-title":"Pediatrics"},{"key":"R17-32-20210202","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1001\/jama.296.16.1990","article-title":"Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.","volume":"96","author":"Hambidge","year":"2006","journal-title":"JAMA"},{"key":"R18-32-20210202","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archpedi.158.11.1031","article-title":"Safety of the trivalent inactivated influenza vaccine among children: a population-based study.","volume":"158","author":"France","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R19-32-20210202","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R20-32-20210202","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1016\/S0264-410X(01)00237-7","article-title":"Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination.","volume":"19","author":"Niu","year":"2001","journal-title":"Vaccine"},{"key":"R21-32-20210202","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The vaccine adverse event reporting system (VAERS).","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"key":"R22-32-20210202","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00002018-200225030-00001","article-title":"Monitoring the safety of vaccines: assessing the risks.","volume":"25","author":"Ellenberg","year":"2002","journal-title":"Drug Saf"},{"key":"R24-32-20210202","first-page":"577","article-title":"Intussusception among recipients of rotavirus vaccine\u2014United States, 1998\u20131999.","volume":"48","year":"1999","journal-title":"Morb Mortal Wkly Rep"},{"key":"R25-32-20210202","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/jama.1997.03550140068042","article-title":"Hair loss after routine immunizations.","volume":"278","author":"Wise","year":"1997","journal-title":"JAMA"},{"key":"R26-32-20210202","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/pds.998","article-title":"A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001.","volume":"13","author":"Zhou","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R27-32-20210202","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain-Barr\u00e9 syndrome and the 1992\u201393 and 1993\u201394 influenza vaccines.","volume":"339","author":"Lasky","year":"1998","journal-title":"N Eng J Med"},{"key":"R28-32-20210202","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/154.11.1006","article-title":"Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination.","volume":"154","author":"Verstraeten","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R29-32-20210202","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1542\/peds.107.6.e97","article-title":"Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system.","volume":"107","author":"Zanardi","year":"2001","journal-title":"Pediatrics"},{"issue":"110","key":"R30-32-20210202","article-title":"Design and estimation for the National Health Interview Survey, 1985\u20131994. National Center for Health Statistics.","volume":"2","author":"Massey","year":"1989","journal-title":"Vital Health Stat"},{"key":"R32-32-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system.","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am Stat"},{"key":"R33-32-20210202","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2165\/00002018-200831080-00003","article-title":"Effects of stratification on data mining in the US Vaccine Adverse Event Reporting System.","volume":"31","author":"Woo","year":"2008","journal-title":"Drug Saf"},{"key":"R34-32-20210202","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.294.21.2720","article-title":"Adverse events reported following live, cold-adapted, intranasal influenza vaccine.","volume":"294","author":"Izurieta","year":"2005","journal-title":"JAMA"},{"key":"R36-32-20210202","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"key":"R37-32-20210202","first-page":"1153","article-title":"Experiences with obtaining influenza vaccination among persons in priority groups during a vaccine shortage\u2014United States, October\u2013November, 2004.","volume":"53","author":"Blendon","year":"2004","journal-title":"Morb Mortal Wkly Rep"},{"key":"R38-32-20210202","first-page":"1183","article-title":"Updated interim influenza vaccination recommendations\u20142004\u20132005 influenza season.","volume":"53","year":"2004","journal-title":"Morb Mortal Wkly Rep"},{"key":"R39-32-20210202","first-page":"1","article-title":"Outbreak of Swine-origin influenza A (H1N1) virus infection\u2013Mexico, March\u2013April 2009.","volume":"58","year":"2009","journal-title":"Morb Mortal Wkly Rep"},{"issue":"RR-10","key":"R41-32-20210202","first-page":"1","article-title":"Use of influenza A (H1N1) 2009 monovalent vaccine. Recommendations of the Advisory Committee on Immunization Practices.","volume":"58","year":"2009","journal-title":"Morb Mortal Wkly Rep"},{"key":"R42-32-20210202","first-page":"750","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA.","volume":"302","author":"Slade","year":"19","journal-title":""},{"key":"R43-32-20210202","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/j.vaccine.2007.02.075","article-title":"Safety review of the purified chick embryo cell rabies vaccine: data from the Vaccine Adverse Event Reporting System (VAERS), 1997\u20132005.","volume":"25","author":"Dobardzic","year":"2007","journal-title":"Vaccine"},{"key":"R44-32-20210202","first-page":"279","article-title":"The epidemiology of fatalities reported to the Vaccine Adverse Event Reporting System 1990\u20131997.","volume":"10","author":"Silvers","year":"2001","journal-title":"Drug Saf"},{"key":"R45-32-20210202","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1542\/peds.2008-0939","article-title":"Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures.","volume":"121","year":"2008","journal-title":"Pediatrics"},{"key":"R46-32-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/aje\/kwp345","article-title":"Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.","volume":"171","author":"Greene","year":"2010","journal-title":"Am J Epidemiol"},{"key":"R47-32-20210202","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents.","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"key":"R48-32-20210202","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1542\/peds.2008-1002","article-title":"An algorithm for treatment of patients with hypersensitivity reactions after vaccines.","volume":"122","author":"Wood","year":"2008","journal-title":"Pediatrics"},{"key":"R49-32-20210202","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/S0264-410X(02)00252-9","article-title":"Medication errors reported to the Vaccine Adverse Event Reporting System (VAERS).","volume":"20","author":"Varricchio","year":"2002","journal-title":"Vaccine"},{"key":"R50-32-20210202","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1081\/CLT-120037427","article-title":"Frequency and nature of recorded childhood immunization-related errors in Greece.","volume":"42","author":"Petridou","year":"2004","journal-title":"J Toxicol Clin Toxicol"},{"key":"R52-32-20210202","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/01.smj.0000216513.73448.af","article-title":"Follow-up study of medication errors reported to the vaccine adverse event reporting system (VAERS).","volume":"99","author":"Varricchio","year":"2006","journal-title":"South Med J"},{"key":"R53-32-20210202","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1016\/j.vaccine.2009.04.005","article-title":"Pediatric vaccination errors: application of the 5 rights framework to a national error reporting database.","volume":"27","author":"Bundy","year":"2009","journal-title":"Vaccine"},{"key":"R54-32-20210202","first-page":"364","article-title":"Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine\u2014United States, October 2005\u2013February 2006.","volume":"55","year":"2006","journal-title":"Morb Mortal Wkly Rep"},{"key":"R55-32-20210202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977.","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"R56-32-20210202","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","article-title":"Vaccines and Guillain-Barr\u00e9 syndrome-review.","volume":"32","author":"Haber","year":"2009","journal-title":"Drug Saf"},{"key":"R57-32-20210202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pds.613","article-title":"The Vaccine Safety Datalink project.","volume":"10","author":"DeStefano","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R58-32-20210202","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barr\u00e9 syndrome worldwide: a systematic literature review.","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201101000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:35:41Z","timestamp":1786041341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201101000-00032"}},"subtitle":["Analysis of the Vaccine Adverse Event Reporting System"],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181ff9795","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}